Catherine Boule

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France.

Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France.

Karista SAS is an Independent Venture Capital firm founded in 2000. Cap Décisif Management SAS is headquartered in Paris, France.

Incepto Medical SAS develops and distributes artificial intelligent (AI) based medical imaging applications. It offers solutions for computed tomography (CT) scans, chest x-ray, and detections for conditions such as fracture and bowel occlusion. The company was founded by Antoine Jomier, Florence Moreau, Vincent Barrau, Jean Michel Malbrancq, and Gaspard d’Assignies and is headquartered in Paris, France.

Incepto Medical SAS develops and distributes artificial intelligent (AI) based medical imaging applications. It offers solutions for computed tomography (CT) scans, chest x-ray, and detections for conditions such as fracture and bowel occlusion. The company was founded by Antoine Jomier, Florence Moreau, Vincent Barrau, Jean Michel Malbrancq, and Gaspard d’Assignies and is headquartered in Paris, France.

Incepto Medical SAS develops and distributes artificial intelligent (AI) based medical imaging applications. It offers solutions for computed tomography (CT) scans, chest x-ray, and detections for conditions such as fracture and bowel occlusion. The company was founded by Antoine Jomier, Florence Moreau, Vincent Barrau, Jean Michel Malbrancq, and Gaspard d’Assignies and is headquartered in Paris, France.

Incepto Medical SAS develops and distributes artificial intelligent (AI) based medical imaging applications. It offers solutions for computed tomography (CT) scans, chest x-ray, and detections for conditions such as fracture and bowel occlusion. The company was founded by Antoine Jomier, Florence Moreau, Vincent Barrau, Jean Michel Malbrancq, and Gaspard d’Assignies and is headquartered in Paris, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Watchfrog SA creates and markets solutions for the in vivo detection of chemical, pharmaceutical and cosmetic substances. The firm offers to incorporate in vivo significance to early in vitro stage of drug discovery. It also offers biotechnological tools to accelerate environmental risk assessment. The company was founded by Barbara Demeneix and Gregory Lemkine in 2005 and is headquartered in Evry, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Watchfrog SA creates and markets solutions for the in vivo detection of chemical, pharmaceutical and cosmetic substances. The firm offers to incorporate in vivo significance to early in vitro stage of drug discovery. It also offers biotechnological tools to accelerate environmental risk assessment. The company was founded by Barbara Demeneix and Gregory Lemkine in 2005 and is headquartered in Evry, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Karista SAS is an Independent Venture Capital firm founded in 2000. Cap Décisif Management SAS is headquartered in Paris, France.

Karista SAS is an Independent Venture Capital firm founded in 2000. Cap Décisif Management SAS is headquartered in Paris, France.

Karista SAS is an Independent Venture Capital firm founded in 2000. Cap Décisif Management SAS is headquartered in Paris, France.

Prestodiag SAS develops, manufactures and markets a life science developments platform aimed at reducing the time and effort to detect microbiological pathogens. Its products include MonoPresto and Detection Kits. The company was founded by Thierry Livache, Thibaut Mercey and Felix Piat in March 2012 and is headquartered in Villejuif, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Karista SAS is an Independent Venture Capital firm founded in 2000. Cap Décisif Management SAS is headquartered in Paris, France.

Karista SAS is an Independent Venture Capital firm founded in 2000. Cap Décisif Management SAS is headquartered in Paris, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Prestodiag SAS develops, manufactures and markets a life science developments platform aimed at reducing the time and effort to detect microbiological pathogens. Its products include MonoPresto and Detection Kits. The company was founded by Thierry Livache, Thibaut Mercey and Felix Piat in March 2012 and is headquartered in Villejuif, France.

Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France.

Prestodiag SAS develops, manufactures and markets a life science developments platform aimed at reducing the time and effort to detect microbiological pathogens. Its products include MonoPresto and Detection Kits. The company was founded by Thierry Livache, Thibaut Mercey and Felix Piat in March 2012 and is headquartered in Villejuif, France.

Karista SAS is an Independent Venture Capital firm founded in 2000. Cap Décisif Management SAS is headquartered in Paris, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France.

Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France.